Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Online cash advance loans - payday advance no fax.
Popular Articles
Natural Remedies

House Democrats Unveil Health Care Reform Proposal
House Democratic leaders on Tuesday unveiled a health care reform bill that aims to extend coverage to 37 million U.S. residents over 10 years, the Washington Post reports. According to Democratic aides, the bill would ensure that 97% of U.S. residents are insured by 2015 (Montgomery/Connolly, Washington Post, 7/15). The bill would require employers and individuals to get health insurance coverage or pay into a fund (AP/Google.com, 7/14). To help people obtain insurance, the bill would increase Medicaid eligibility and provide tax credits to those with incomes up to 400% of the federal poverty level, or about $43,000 for an individual (Washington Post, 7/15). The bill would establish a government-run public plan option designed to compete with private insurers (Frank, Reuters, 7/14). The bill also includes several provisions designed to slow the growth of Medicare (Pear/Herszenhorn, New York Times, 7/15).The bill does not include total cost figures, and it is unclear whether last-minute changes by its sponsors would satisfy moderate and conservative Democrats who last week refused to support the legislation, according to the AP/Google.com (AP/Google.com, 7/14). The Congressional Budget Office estimated yesterday that the bill would cost $1 trillion over 10 years, though more information is needed before final cost estimates are released. A new surtax on higher-income residents is projected to cover more than half of the bill"s cost over 10 years, with smaller amounts of funding from changes to the corporate tax code, according to the Post (Washington Post, 7/15).
generic viagra online
Amarillo, Texas To Use State Grant For HIV Surveillance Activities
The Amarillo, Texas City Commission on Tuesday received a grant from the Texas Department of State Health Services, of which $51,636 will be used for HIV surveillance activities across the Texas Panhandle Region, NewsChannel10.com reports. According to NewsChannel10.com, the "grant supports the investigation, review and reporting of HIV/AIDS positive cases to the State Health Department" (Lemmons, 7/15).
News of the day
Abbott And AstraZeneca Submit New Drug Application To The FDA For CERTRIAD(TM), An Investigational Treatment For Mixed Dyslipidemia
Abbott (NYSE: ABT) and AstraZeneca announced that the companies have submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for an investigational compound for the treatment of mixed dyslipidemia, a combination of two or more lipid abnormalities including high LDL- cholesterol (the "bad" cholesterol), high triglycerides and low HDL-cholesterol (the "good" cholesterol). The NDA submission for this investigational compound, containing the active ingredients of CRESTOR(R) (rosuvastatin calcium) and TRILIPIX(R) (fenofibric acid), is supported by data from multiple studies, including efficacy and safety studies with the 5mg, 10mg and 20mg doses of rosuvastatin combined with fenofibric acid. Pending approval of the NDA, the treatment will be marketed as CERTRIAD(TM).
Diagnostics

Pioneering Research Into Healing Power Of Sugar

A pioneering University of Wolverhampton lecturer has won a ÷£25,000 grant to research the healing effect of sugar on cuts and wounds. Senior Lecturer Moses Murandu grew up in Zimbabwe and his father used granulated sugar to heal wounds and reduce pain when he was a child. But when he moved to the UK, he realised that sugar was not used for this purpose here. Moses, 43, carried out research into the effect of sugar on patients" wounds on the vascular ward at Selly Oak Hospital in Birmingham, funding the study himself for six months. He has now been awarded the prestigious Fondation Le Lous Scientific Research Innovation Award and ÷£25,000 to enable him to continue his innovative work. Sugar can be used on wounds such as bed sores, leg ulcers and even amputations. It works because bacteria needs water to grow, so applying sugar to a wound draws the water away and starves the bacteria of water. This prevents the bacteria from multiplying and they die. Moses found that a 25% sugar concentration ensures the microorganisms cannot survive. Mr Murandu, Senior Lecturer in Adult Nursing at the School of Health and Well Being, said: "Using granulated sugar in wounds has never been done in the UK before, although sugar paste has been used. When I was a child, my father used sugar or salt and I grew up without realising that something that works is not widely used. "While salt is painful, sugar is not and reduces the pain drastically. The patients we have tested it on in the pilot study have said that they never knew such a simple method could make such a difference to their quality of life. "I was happy for the patients who suffer from terrible and debilitating wounds with little hope of getting better, as this treatment can ease their pain." Jacqui Fletcher, Herve Le Lous Board Member, said: "Moses was awarded the prize not just because the quality of his proposal was excellent, but also because he challenged current thinking. In the UK we have a habit of saying "Ah yes we know in countries that can"t afford proper dressings they use other things, but when you are here you have the freedom and luxury of choosing a whole range of alternatives", but Moses didn"t think that way. He takes the view that he used sugar very effectively, therefore why wouldn"t it work equally well here? He should be commended for his tenacity in taking this project forward when many others would not even have started." Moses, from Edgbaston in Birmingham, was supported in his studies by Mr Malcolm Simms, consultant vascular surgeon at Selly Oak Hospital, who had worked in Uganda and witnessed the use of sugar there. Mr Murandu submitted an abstract to the Fondation Le Lous detailing his study and the benefits for patients. As well as ÷£25,000 over two years to further his research, Moses received a trophy and will also receive support from board member Carol Dealey, who is a Research Fellow at the University Hospital Birmingham NHS Foundation Trust and University of Birmingham. Originally from Zimbabwe, Moses Murandu studied midwifery in South Africa and also studied in Atlanta, Georgia, before coming to the UK to study a Masters at Birmingham University, supported by Professor Colette Clifford. As well as lecturing at the University of Wolverhampton, he is currently studying for a doctorate at Birmingham. University of Wolverhampton


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009